Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
46.66
+0.04 (0.09%)
Mar 3, 2026, 2:15 PM EST - Market open
Veradermics Market Cap
Veradermics has a market cap or net worth of $1.74 billion as of March 3, 2026.
Market Cap
1.74B
Enterprise Value
1.65B
1-Year Change
n/a
Ranking
Category
Stock Price
$46.66
Market Cap Chart
Since the IPO on February 4, 2026, Veradermics's market cap has increased from $1.32B to $1.74B, an increase of 31.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.71B | 6.85% |
| Feb 26, 2026 | 1.60B | 1.75% |
| Feb 25, 2026 | 1.57B | -3.70% |
| Feb 24, 2026 | 1.64B | -2.69% |
| Feb 23, 2026 | 1.68B | 1.15% |
| Feb 20, 2026 | 1.66B | -7.93% |
| Feb 19, 2026 | 1.80B | -3.51% |
| Feb 18, 2026 | 1.87B | 5.70% |
| Feb 17, 2026 | 1.77B | 9.02% |
| Feb 13, 2026 | 1.62B | -2.21% |
| Feb 12, 2026 | 1.66B | 0.91% |
| Feb 11, 2026 | 1.64B | 8.88% |
| Feb 10, 2026 | 1.51B | 9.24% |
| Feb 9, 2026 | 1.38B | -3.77% |
| Feb 6, 2026 | 1.44B | 3.55% |
| Feb 5, 2026 | 1.39B | 4.78% |
| Feb 4, 2026 | 1.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.82B |
| Relay Therapeutics | 1.81B |
| Galecto | 1.81B |
| Palvella Therapeutics | 1.79B |
| Vericel | 1.79B |
| RAPT Therapeutics | 1.79B |
| Intellia Therapeutics | 1.79B |
| Tyra Biosciences | 1.78B |